Novel quinazolin-2-yl 1, 2, 3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study

NFM El Hamaky, A Hamdi, WA Bayoumi, AA Elgazar… - Bioorganic …, 2024 - Elsevier
In our study, a series of quinazoline-1, 2, 3-triazole hybrids (14a-r) have been designed and
synthesized as multi-target EGFR, VEGFR-2, and Topo II inhibitors. All synthesized hybrids …

Pyrimidine-based dual-target inhibitors targeting epidermal growth factor receptor for overcoming drug resistance in cancer therapy (2006-present)

Y An, X Lv, S Xu, H Li, P Zheng, W Zhu… - European Journal of …, 2025 - Elsevier
The epidermal growth factor receptor (EGFR) is a pivotal member of the epidermal growth
factor receptor family, exerting crucial regulatory influence on cellular physiological …

Discovery of pyran annulated heterocyclic scaffolds linked to carboxamide fragments: Anticancer evaluation, topoisomerase I/II, tyrosine kinase receptor inhibition and …

AM Fouda, RA El-Eisawy, MAA El-Nassag… - Journal of Molecular …, 2024 - Elsevier
A class of 4H-benzo [h] chromene (4a-h) and 1H-benzo [f] chromene (6a-h) derivatives
linked to carboxamide/carbothioamide at the 3/2-positions were designed and synthesized …

Design and synthesis of novel pyrazolopyrimidine candidates as promising EGFR-T790M inhibitors and apoptosis inducers

AA Gaber, M Sharaky, AA Elmaaty… - Future Medicinal …, 2023 - Taylor & Francis
Aim: Our objective was to design and synthesize a new range of pyrazolopyrimidines while
maintaining the key pharmacophoric features of EGFR tyrosine kinase inhibitors. Materials & …

Pharmacophore‐based, rationale design, and efficient synthesis of novel tetrahydrobenzo[b]thiophene candidates as potential dual Topo I/II inhibitors and DNA …

HR Nofal, AA Al‐Karmalawy, AA Elmaaty… - Archiv der …, 2024 - Wiley Online Library
A series of tetrahydrobenzo [b] thiophene derivatives was designed and synthesized as dual
topoisomerase (Topo) I/II inhibitors implicating potential DNA intercalation. Ethyl‐2‐amino‐3 …